600
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Our current understanding of clinical characteristics and the genetics of patients with albinism

ORCID Icon, , &
Pages 163-172 | Received 27 Sep 2023, Accepted 14 Feb 2024, Published online: 23 Feb 2024

References

  • Neveu MM, Padhy SK, Ramamurthy S, et al. Ophthalmological manifestations of oculocutaneous and ocular albinism: Current perspectives. Clin Ophthalmol. 2022;16:1569–1587. doi: 10.2147/OPTH.S329282
  • MG T, Zippin J, BP B. Oculocutaneous albinism and ocular albinism overview. Adam MP, Mirzaa GM, Pagon RA, et al., editors. Seattle (WA): University of Washington, Seattle; 1993. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.
  • Kromberg JGR, Flynn KA, Kerr RA. Determining a worldwide prevalence of oculocutaneous albinism: a systematic review. Invest Ophthalmol Vis Sci. 2023;64(10):14. doi: 10.1167/iovs.64.10.14
  • Tsang SH, Sharma T. X-linked Ocular Albinism. Adv Exp Med Biol. 2018;1085:49–52.
  • Bakker R, Wagstaff EL, Kruijt CC, et al. The retinal pigmentation pathway in human albinism: not so black and white. Prog Retin Eye Res. Prog Retin Eye Res. 2022;91:101091
  • Gronskov K, Ek J, Brondum-Nielsen KOA. Oculocutaneous albinism. Orphanet J Rare Dis. 2007;2(1):43–43. doi: 10.1186/1750-1172-2-43
  • Kausar T, Bhatti MA, Ali M, et al. OCA5, a novel locus for non-syndromic oculocutaneous albinism, maps to chromosome 4q24. Clin Genet. 2013;84(1):91–93. doi: 10.1111/cge.12019
  • O’Donnell FEJ, Green WR, Fleischman JA, Hambrick GW. X-linked ocular albinism in blacks. Ocular Albinism Cum Pigmento Arch Ophthalmol. 1978;96(7):1189–1192. doi: 10.1001/archopht.1978.03910060023005
  • Summers CG. Albinism: classification, clinical characteristics, and recent findings. Optom Vis Sci. 2009;86(6):659–662. doi: 10.1097/OPX.0b013e3181a5254c
  • Ma EZ, Zhou AE, Hoegler KM, et al. Oculocutaneous albinism: epidemiology, genetics, skin manifestation, and psychosocial issues. Arch Dermatol Res. 2023;315(2):107–116. doi: 10.1007/s00403-022-02335-1
  • Dessinioti C, Stratigos AJ, Rigopoulos D, et al. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Exp Dermatol. 2009;18(9):741–749. doi: 10.1111/j.1600-0625.2009.00896.x
  • Oetting WS, King RA. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat. 1999;13(2):99–115. doi: 10.1002/(SICI)1098-1004(1999)13:2<99:AID-HUMU2>3.0.CO;2-C
  • Rundshagen U, Zuhlke C, Opitz S, et al. Mutations in the MATP gene in five German patients affected by oculocutaneous albinism type 4. Hum Mutat. 2004;23(2):106–110. doi: 10.1002/humu.10311
  • Inagaki K, Suzuki T, Shimizu H, et al. Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan. Am J Hum Genet. 2004;74(3):466–471. doi: 10.1086/382195
  • Hayashi M, Suzuki T. Oculocutaneous albinism type 4. Adam MP, Feldman J, Mirzaa GM, et al., editors. Seattle (WA): University of Washington, Seattle; 1993. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.
  • Anshelevich EE, Mosojane KI, Kenosi L, et al. Factors affecting quality of life for people living with albinism in Botswana. Dermatol Clin. 2021;39(1):129–145. doi: 10.1016/j.det.2020.08.012
  • Summers CG, Knobloch WH, Witkop CJJ, et al. Hermansky-pudlak syndrome. Ophthalmic Findings Ophthalmology. 1988;95(4):545–554. doi: 10.1016/S0161-6420(88)33152-0
  • Papageorgiou E, McLean RJ, Gottlob I. Nystagmus in childhood. Pediatr Neonatol. 2014;55(5):341–351. doi: 10.1016/j.pedneo.2014.02.007
  • Thomas MG, Kumar A, Mohammad S, et al. Structural grading of foveal hypoplasia using spectral-domain optical coherence tomography a predictor of visual acuity? Ophthalmol. 2011;118(8):1653–1660. doi: 10.1016/j.ophtha.2011.01.028
  • Mohammad S, Gottlob I, Kumar A, et al. The functional significance of foveal abnormalities in albinism measured using spectral-domain optical coherence tomography. Ophthalmol. 2011;118(8):1645–1652. doi: 10.1016/j.ophtha.2011.01.037
  • Rufai SR, Thomas MG, Purohit R, et al. Can structural grading of foveal hypoplasia predict future vision in infantile nystagmus? A longitudinal study. Ophthalmol. 2020;127(4):492–500. doi: 10.1016/j.ophtha.2019.10.037
  • Dumitrescu AV, Tran J, Pfeifer W, et al. Clinical albinism score, presence of nystagmus and optic nerves defects are correlated with visual outcome in patients with oculocutaneous albinism. Ophthalmic Genet. 2021;42(5):539–552. doi: 10.1080/13816810.2021.1933544
  • Kuht HJ, Maconachie GDE, Han J, et al. Genotypic and phenotypic spectrum of Foveal Hypoplasia: a multicenter study. Ophthalmol. 2022;129(6):708–718. doi: 10.1016/j.ophtha.2022.02.010
  • Kruijt CC, Gradstein L, Bergen AA, et al. The Phenotypic and Mutational Spectrum of the FHONDA Syndrome and oculocutaneous albinism: similarities and differences. Invest Ophthalmol Vis Sci. 2022;63(1):19. doi: 10.1167/iovs.63.1.19
  • Sheth V, Gottlob I, Mohammad S, et al. Diagnostic potential of iris cross-sectional imaging in albinism using optical coherence tomography. Ophthalmol. 2013;120(10):2082–2090. doi: 10.1016/j.ophtha.2013.03.018
  • Yahalom C, Tzur V, Blumenfeld A, et al. Refractive profile in oculocutaneous albinism and its correlation with final visual outcome. Br J Ophthalmol. 2012;96(4):537–539. doi: 10.1136/bjophthalmol-2011-300072
  • Wildsoet CF, Oswald PJ, Clark S. Albinism: its implications for refractive development. Invest Ophthalmol Vis Sci. 2000;41(1):1–7.
  • Schweigert A, Lunos S, Connett J, et al. Changes in refractive errors in albinism: a longitudinal study over the first decade of life. J AAPOS. 2018;22(6):462–466. doi: 10.1016/j.jaapos.2018.08.005
  • Kumar A, Gottlob I, McLean RJ, et al. Clinical and oculomotor characteristics of albinism compared to FRMD7 associated infantile nystagmus. Invest Ophthalmol Vis Sci. 2011;52(5):2306–2313. doi: 10.1167/iovs.10-5685
  • Hertle RW. Albinism: particular attention to the ocular motor system. Middle East Afr J Ophthalmol. 2013;20(3):248–255. doi: 10.4103/0974-9233.114804
  • Abadi RV. Motor and sensory characteristics of infantile nystagmus. Br J Ophthalmol. 2002;86(10):1152–1160. doi: 10.1136/bjo.86.10.1152
  • Brodsky MC, Fray KJ. Positive angle kappa: a sign of albinism in patients with congenital nystagmus. Am J Ophthalmol. 2004;137(4):625–629. doi: 10.1016/j.ajo.2003.11.066
  • Ramtohul P, Comet A, Denis D. Multimodal imaging correlation of the concentric macular rings sign in foveal hypoplasia: a distinctive henle fiber layer geometry. Ophthalmol Retina. 2020;4(9):946–953. doi: 10.1016/j.oret.2020.03.022
  • Marti A, Lasseaux E, Ezzedine K. Lessons of a day hospital: comprehensive assessment of patients with albinism in a European setting. Pigment Cell Melanoma Res. 2018;31(2):318–329. doi: 10.1111/pcmr.12651
  • Colello RJ, Guillery RW. The early development of retinal ganglion cells with uncrossed axons in the mouse: retinal position and axonal course. Development. 1990;108(3):515–523. doi: 10.1242/dev.108.3.515
  • Gimenez E, Lavado A, Jeffery G, et al. Regional abnormalities in retinal development are associated with local ocular hypopigmentation. J Comp Neurol. 2005;485(4):338–347. doi: 10.1002/cne.20495
  • Wilk MA, Curcio CA, Brilliant MH, et al. Author response: relationship between foveal cone specialization and pit morphology in albinism. Invest Ophthalmol Vis Sci. 2014;55(9):5923–15470. doi: 10.1167/iovs.14-15470
  • Kuht HJ, Han J, Maconachie GDE, et al. SLC38A8 mutations result in arrested retinal development with loss of cone photoreceptor specialization. Hum Mol Genet. 2020;29(18):2989–3002. doi: 10.1093/hmg/ddaa166
  • Mohammad S, Gottlob I, Sheth V, et al. Characterization of abnormal optic nerve head morphology in albinism using optical coherence tomography. Invest Ophthalmol Vis Sci. 2015;56(8):4611–4618. doi: 10.1167/iovs.15-16856
  • Chong GT, Farsiu S, Freedman SF, et al. Abnormal foveal morphology in ocular albinism imaged with spectral-domain optical coherence tomography. Arch Ophthalmol. 2009;127(1):37–44. doi: 10.1001/archophthalmol.2008.550
  • Neveu MM, Holder GE, Sloper JJ, et al. Optic chiasm formation in humans is independent of foveal development. Eur J Neurosci. 2005;22(7):1825–1829. doi: 10.1111/j.1460-9568.2005.04364.x
  • Hoffmann MB, Lorenz B, Morland AB, et al. Misrouting of the optic nerves in albinism: estimation of the extent with visual evoked potentials. Invest Ophthalmol Vis Sci. 2005;46(10):3892–3898. doi: 10.1167/iovs.05-0491
  • Thomas MG, Maconachie GD, Sheth V, et al. Development and clinical utility of a novel diagnostic nystagmus gene panel using targeted next-generation sequencing. Eur J Hum Genet. 2017;25(6):725–734. doi: 10.1038/ejhg.2017.44
  • Liu S, Kuht HJ, Moon EH, et al. Current and emerging treatments for albinism. Surv Ophthalmol. 2021;66(2):362–377. doi: 10.1016/j.survophthal.2020.10.007
  • Okamura K, Suzuki T. Current landscape of Oculocutaneous Albinism in Japan. Pigment Cell Melanoma Res. 2021;34(2):190–203. doi: 10.1111/pcmr.12927
  • Wei AH, Zang DJ, Zhang Z, et al. Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic oculocutaneous albinism. J Invest Dermatol. 2013 Jul 1;133(7):1834–40. doi: 10.1038/jid.2013.49
  • Grønskov K, Dooley CM, Østergaard E, et al. Mutations in c10orf11, a melanocyte-differentiation gene, cause autosomal-recessive albinism. Am J Hum Genet. 2013 Mar 7;92(3):415–21. doi: 10.1016/j.ajhg.2013.01.006
  • Pennamen P, Tingaud-Sequeira A, Gazova I, et al. Dopachrome tautomerase variants in patients with oculocutaneous albinism. Genet Med. 2021 Mar 1;23(3):479–87. doi: 10.1038/s41436-020-00997-8
  • Self JE, Dunn MJ, Erichsen JT, et al. Management of nystagmus in children: a review of the literature and current practice in UK specialist services. Eye (Lond). 2020;34(9):1515–1534. doi: 10.1038/s41433-019-0741-3
  • Clark R, Blundell J, Dunn MJ, et al. The potential and value of objective eye tracking in the ophthalmology clinic. Eye (Lond). 2019;33(8):1200–1202. doi: 10.1038/s41433-019-0417-z
  • Tyedmers M, Roper-Hall G. The harms tangent screen test. Am Orthopt J. 2006;56(1):175–179. doi: 10.3368/aoj.56.1.175
  • Odom JV, Bach M, Brigell M, et al. ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol. 2016;133(1):1–9. doi: 10.1007/s10633-016-9553-y
  • Huang SJ, Amendola LM, Sternen DL. Variation among DNA banking consent forms: points for clinicians to bank on. J Comm Genet. 2022;13(4):389–397. doi: 10.1007/s12687-022-00601-3
  • Gronskov K, Jespersgaard C, Bruun GH, et al. A pathogenic haplotype, common in Europeans, causes autosomal recessive albinism and uncovers missing heritability in OCA1. Sci Rep. 2019;9(1):645–018–37272–37275. doi: 10.1038/s41598-018-37272-5
  • Loftus SK, Gillis MF, Lundh L, et al. Haplotype-based analysis resolves missing heritability in oculocutaneous albinism type 1B. Am J Hum Genet. 2023;110(7):1123–1137. doi: 10.1016/j.ajhg.2023.05.012
  • Michaud V, Lasseaux E, Green DJ, et al. The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism. Nat Commun. 2022;13(1):3939. doi: 10.1038/s41467-022-31392-3
  • Loftus SK, Lundh L, Watkins-Chow DE, et al. A custom capture sequence approach for oculocutaneous albinism identifies structural variant alleles at the OCA2 locus. Hum Mutat. 2021;42(10):1239–1253. doi: 10.1002/humu.24257
  • Kuht HJ, Thomas MG, McLean RJ, et al. Abnormal foveal morphology in carriers of oculocutaneous albinism. Br J Ophthalmol. 2023;107(8):1202–1208. doi: 10.1136/bjophthalmol-2020-318192
  • Surace EM, Domenici L, Cortese K, et al. Amelioration of both functional and morphological abnormalities in the retina of a mouse model of ocular albinism following AAV-mediated gene transfer. Mol Ther. 2005;12(4):652–658. doi: 10.1016/j.ymthe.2005.06.001
  • Song Y, Zhang Y, Chen M, et al. Functional validation of the albinism-associated tyrosinase T373K SNP by CRISPR/Cas9-mediated homology-directed repair (HDR) in rabbits. EBioMedicine. 2018;36:517–525. doi: 10.1016/j.ebiom.2018.09.041
  • George A, Sharma R, Pfister T, et al. In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium. Stem Cell Rep. 2022;17(1):173–186. doi: 10.1016/j.stemcr.2021.11.016
  • van Beest E, Mukherjee S, Kirchberger L, et al. A fovea-like representation of space in mouse visual cortex. SSRN Electron J. 2019. doi:10.2139/ssrn.3441090
  • Jayaramachandran P, Proudlock FA, Odedra N, et al. A randomized controlled trial comparing soft contact lens and rigid gas-permeable lens wearing in infantile nystagmus. Ophthalmol. 2014;121(9):1827–1836. doi: 10.1016/j.ophtha.2014.03.007
  • Jhetam S, Mashige KP. Effects of spectacles and telescopes on visual function in students with oculocutaneous albinism. Afr Health Sci. 2020;20(2):758–767. doi: 10.4314/ahs.v20i2.28
  • Villegas VM, Diaz L, Emanuelli A, et al. Visual acuity and nystagmus following strabismus surgery in patients with oculocutaneous albinism. P R Health Sci J. 2010;29(4):391–393.
  • Human Rights Council thirty-first session agenda item 3 promotion and protection of all human rights, civil, political, economic, social and cultural rights, including the right to development report of the Independent expert on the enjoyment of human rights by persons with albinism note by the secretariat.
  • Lee H, Sheth V, Bibi M, et al. Potential of handheld optical coherence tomography to determine cause of infantile nystagmus in children by using foveal morphology. Ophthalmol. 2013 Dec 1;120(12):2714–24. doi: 10.1016/j.ophtha.2013.07.018
  • Penix K, Swanson MW, DeCarlo DK. Nystagmus in pediatric patients: interventions and patient-focused perspectives. Clin Ophthalmol. 2015;9:1527–1536. doi: 10.2147/OPTH.S62786
  • Biswas S, IC L. Oculocutaneous albinism. Arch Dis Child. 1999;80(6):565–569. doi: 10.1136/adc.80.6.565
  • Fulcher T, O’Keefe M, Bowell R, et al. Intellectual and educational attainment in albinism. J Pediatr Ophthalmol Strabismus. 1995;32(6):368–372. doi: 10.3928/0191-3913-19951101-09